The Law Office of Joseph Klein is investigating the Board of Directors of Dionex Corporation (NasdaqGS: DNEX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Thermo Fisher Scientific (NYSE: TMO). Under the terms of the proposed transaction, Thermo Fisher will acquire all of the outstanding shares of Dionex for $118.50 in cash per share for a total purchase price of approximately $2.1 billion.

The investigation concerns whether the Dionex Board of Directors breached their fiduciary duties to Dionex stockholders by failing to adequately shop the Company before entering into this transaction and whether Thermo Fisher is underpaying for Dionex shares, thus unlawfully harming Dionex stockholders.

If you own common stock in Dionex and wish to obtain additional information, please contact Joseph Klein, Esq. directly, via email at jk@jkleinlawfirm.com, by telephone at 718-947-0005, Toll Free: 877-STOK-180, or visit http://www.jkleinlawfirm.com/dionexcorporation-dnex.html.

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

Dionex Corp. (MM) (NASDAQ:DNEX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Dionex Corp. (MM)
Dionex Corp. (MM) (NASDAQ:DNEX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Dionex Corp. (MM)